Cargando…
Preparative Synthesis of an R(P)-Guanosine-3′,5′-Cyclic Phosphorothioate Analogue, a Drug Candidate for the Treatment of Retinal Degenerations
[Image: see text] Cyclic guanosine monophosphorothioate analogue 1a is currently showing potential as a drug for the treatment of inherited retinal neurodegenerations. To support ongoing preclinical and clinical work, we have developed a diastereoselective synthesis via cyclization and sulfurization...
Autores principales: | Pérez, Oswaldo, Schipper, Nicolaas, Bollmark, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609652/ https://www.ncbi.nlm.nih.gov/pubmed/34840493 http://dx.doi.org/10.1021/acs.oprd.1c00230 |
Ejemplares similares
-
Crystal Modifications of a Cyclic Guanosine Phosphorothioate Analogue, a Drug Candidate for Retinal Neurodegenerations
por: Pérez, Oswaldo, et al.
Publicado: (2023) -
Synthesis of phosphorothioates using thiophosphate salts
por: Kaboudin, Babak, et al.
Publicado: (2006) -
Monovalent selectivity of the cyclic guanosine monophosphate-activated ion channel
Publicado: (1990) -
Regulation of Biofilm Exopolysaccharide Production by Cyclic Di-Guanosine Monophosphate
por: Poulin, Myles B., et al.
Publicado: (2021) -
Calcium effects on frog retinal cyclic guanosine 3’,5’- monophosphate levels and their light-initiated rate of decay
por: Kilbride, P
Publicado: (1980)